Skip to content
healthcare.dev

Olmesartan Medoxomil and Hydrochlorothiazide

NDC 70518-2269, Olmesartan Medoxomil and Hydrochlorothiazide, tablet, from REMEDYREPACK INC..

Product NDC
70518-2269
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204233
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2269 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL40 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
70518-2269-07051822690090 TABLET in 1 BOTTLE, PLASTIC (70518-2269-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/de815d64-b8d4-46a8-95b8-c230abe7f767

Use it

Look up 70518-2269 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2269 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-2269. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.